The PGY2 Investigational Drugs and Research Residency Program is an ASHP pre-candidate residency at UW Medicine. This program provides twelve months of training designed to develop and refine expert skills necessary in the pharmacist’s provision of care for patients enrolled in clinical trials. The primary practice sites include Fred Hutchinson Cancer Center (FHCC) and University of Washington Medical Center Montlake Campus (UWMC-ML). The Investigational Drug Services Pharmacy department currently manages over 350 clinical trials, providing residents with opportunities in a wide variety of research areas including Oncology, non-Oncology, COVID-19, Industry-sponsored, Investigator-initiated and NCI funded Phase I-III clinical trials. Residents work independentl